Ceftoral

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceftoral

Quick Facts

Property Description
Active ingredient Cefixime
Form Tablet, Capsule, Oral Suspension
Pharmacological class Third-generation Cephalosporin, Beta-Lactam Antibiotic
Common use (General) Combating bacterial infections
Origin Semisynthetic

What Type of Medicine is Ceftoral?

Ceftoral is a prescription-only medication containing the active ingredient Cefixime, a semisynthetic beta-lactam antibiotic. It is precisely classified as a third-generation cephalosporin, a designation reflecting its position within the broader family of anti-infective agents. The general purpose of this medicine is to serve as a bactericidal agent, providing systemic defense by combating illnesses caused exclusively by susceptible bacterial invasion.

Cefixime is effective against a broad range of Gram-negative bacteria. This effectiveness is clinically recognized, particularly in treating specific bacterial infections where the pathogen is known to be susceptible to third-generation cephalosporins. This medicine is often positioned for patients requiring an orally administered antibiotic capable of systemic action, avoiding the need for injection.


Composition and Mechanism of Action

Ceftoral is a single-ingredient product (monotherapy) that functions by destroying the bacterial cell wall. Cefixime, the core component, achieves this by interfering with the vital process of cell wall synthesis, acting as a bactericidal agent that actively kills the target bacteria. This mechanism is critical for the rapid and decisive elimination of the bacterial population, which is essential for resolving the core infection.

Third-generation agents like Cefixime possess an ability to penetrate the bacterial wall and bind to essential proteins compared to older drugs in the class. This binding capability contributes to the medicine's potency. Ceftoral is available in several oral preparations, including tablets, capsules, and liquid oral suspensions, with the liquid form often favored for pediatric patients. It is important to note that because the mechanism specifically targets bacterial biological processes, this medication is not effective against viral infections like the common cold or influenza.

Regulatory References

  1. NIH DailyMed: Cefixime Capsule Label
  2. Cefixime: MedlinePlus Drug Information
  3. Third-Generation Cephalosporins - NCBI/NIH StatPearls
  4. Cephalosporins - NCBI/NIH StatPearls

What side effects are possible with Ceftoral?

Possible Side Effects and Safety Information: Ceftoral

Ceftoral (cefaclor) is generally well-tolerated, but like all medications, it can cause side effects. These effects are usually mild and temporary. It is important to inform your healthcare provider if any side effects persist or worsen.


Common Side Effects

These effects are typically mild and may not require medical attention unless severe or persistent.

System Side Effect
Gastrointestinal Diarrhea, Nausea, Vomiting
Dermatologic Rash, Hives (Urticaria)
Other Vaginitis (in women), Eosinophilia

Less Common and Serious Side Effects

Immediately seek emergency medical attention if you experience any signs of a serious allergic reaction (anaphylaxis), such as severe rash, itching, swelling of the face, tongue, or throat, dizziness, or trouble breathing.

Other serious, though rare, side effects include severe skin reactions (e.g., Stevens-Johnson syndrome), liver problems, and blood disorders. Prolonged use may lead to a secondary infection, such as Clostridioides difficile-associated diarrhea (C. difficile colitis), which can range from mild diarrhea to life-threatening inflammation of the colon.


Safety and Precautions

Before taking Ceftoral, discuss your full medical history with your doctor, especially if you have a history of penicillin or cephalosporin allergy, kidney disease, or gastrointestinal disease (particularly colitis). Ceftoral may interfere with certain laboratory tests, such as the Coombs test. Do not stop taking this medication prematurely, even if you feel better, to prevent the development of antibiotic resistance.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Ceftoral (Cefixime) outlines specific manifestations and mandatory emergency actions for overdose situations.

Documented Manifestations and Severe Outcomes

Overdose exposure is documented to present with gastrointestinal disturbances, including nausea, vomiting, and diarrhea. The most severe documented effects involve the central nervous system (CNS), where high exposure may lead to reversible encephalopathy and the potential for convulsions or seizures. This neurological toxicity represents the primary serious risk in overdose. Patients with severe renal impairment are explicitly noted to be at an increased risk of these CNS effects.


Mandatory Emergency Intervention

Regulatory guidance mandates that immediate medical attention must be sought for any known or suspected overdose. Emergency services should be contacted immediately if severe neurological signs, such as a convulsion or seizure, are observed. Close clinical monitoring within a hospital setting is typically required to assess the patient’s status.


Overdose Management Constraints

Official labeling states that the management of overdose is restricted to symptomatic and supportive treatment. This approach is necessary because no specific antidote is known for the medicine. Furthermore, regulatory documents specify that Ceftoral is not effectively removed by hemodialysis or peritoneal dialysis, limiting procedural interventions for drug clearance.

Therapeutic Uses of Ceftoral

What Ceftoral Treats: Main Uses and Benefits

Ceftoral (Cefixime) is therapeutically focused on providing systemic support against susceptible bacterial infection. Its use is generally centered on addressing the bacterial presence to help manage symptoms that interfere with daily functioning.


Targeted Therapeutic Relief

This medicine is commonly used to help manage conditions characterized by acute symptomatic episodes, including bacterial infections of the middle ear (acute otitis media), the throat (pharyngitis/tonsillitis), acute exacerbations of chronic bronchitis, and uncomplicated urinary tract infections (UTIs). It is also considered relevant for certain specific sexually transmitted infections.

“The therapeutic assistance generally supports the patient during the difficult episodes by contributing to easing the overall symptom load.”

In these contexts, Ceftoral helps address symptom clusters such as localized pain, fever, inflammation, and urogenital discomfort. Its application is relevant for easing challenging symptoms that create noticeable functional strain.

Quick Fact: Relief for Acute Discomfort
Primary Goal Easing symptomatic discomfort in conditions involving bacterial presence.
Benefit Supports improved day-to-day comfort.
Typical Context Uncomplicated infections and acute exacerbations.

The support provided by Ceftoral assists with maintaining functional support and provides supportive relief when symptoms become temporarily overwhelming.

Regulatory References

  1. NIH MedlinePlus overview of Cefixime

Eligibility and Restrictions for Use

Official Eligibility Rules for Ceftoral

Regulatory labeling dictates specific patient populations for whom the use of Ceftoral (Cefixime) is permitted, restricted, or strictly prohibited. This information is derived solely from government-approved prescribing documents.

Category Official Regulatory Statement
Populations for whom use is allowed Adults and Pediatric Patients aged 6 months and older are approved for use under standard labeled conditions.
Populations for whom use is contraindicated Patients with known hypersensitivity to Cefixime or any other cephalosporin antibiotic.
Patients with a history of severe, immediate allergic reaction to penicillins (due to potential cross-reactivity).
Age-related eligibility rules Infants aged less than 6 months (Safety and efficacy have not been established).
Condition-specific eligibility rules Use in patients with impaired renal function is permitted but requires special consideration and monitoring.
Pregnancy and lactation eligibility Pregnancy: Use is generally classified as conditional, and is restricted to times when it is clearly needed.
Lactation: Regulators advise caution, with consideration for discontinuing nursing temporarily during treatment.

Connection to the Overall Eligibility Profile

The structure of Ceftoral's eligibility profile is primarily determined by absolute prohibitions based on allergic history, minimum age requirements, and cautious, conditional use for patients with impaired kidney function. These regulatory classifications establish the official boundaries for use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ceftoral (Cefixime) interactions are officially documented in regulatory information, focusing on changes in drug exposure and pharmacodynamic effects. No medicinal products are formally designated as contraindicated for co-administration in the official labeling. The tablet and capsule forms of Ceftoral may be taken without regard to food.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance Official Interaction Outcome
Probenecid Increases Cefixime serum concentration by competing for renal tubular clearance (an anionic transport mechanism).
Oral Anticoagulants (e.g., Warfarin) Associated with an increased prothrombin time (PT), which may occur with or without clinical bleeding.
Carbamazepine Co-administration has been reported to lead to elevated plasma levels of Carbamazepine.
Hormonal Contraceptives May reduce the effectiveness of the contraceptive medicine.

These interactions fall into two high-level regulatory domains: those that modify the exposure of Cefixime or the co-administered drug, and those that exhibit a pharmacodynamic effect, such as altering coagulation parameters. Monitoring is required during co-administration with Oral Anticoagulants due to the potential for coagulation changes. There are no mandatory time-based separation rules explicitly stated in the regulatory documentation for co-administered medicines.

Mechanism of Action

Targeting Bacterial Enzyme Activity in Cell Wall Construction

Ceftoral (Cefixime) works by acting as an irreversible inhibitor of Penicillin-Binding Proteins (PBPs), which are enzymes located within the bacterial cell membrane. By binding covalently to the active site of these PBPs, the drug immediately halts the crucial process of peptidoglycan cross-linking, a fundamental step in building the bacteria's rigid external structure.

The Cascade of Structural Failure and Bactericidal Lysis

The drug's molecular interaction initiates a sequence of events leading directly to bacterial cell death. The structural flaw created by blocking peptidoglycan synthesis renders the bacterial cell wall mechanically unstable, causing it to lose its ability to resist high internal osmotic pressure. This culminates in cell lysis (rupture) and the loss of cellular viability in the susceptible bacterial population, consistent with bactericidal classification.

Constraints on Mechanism Due to Resistance

The core pharmacodynamic action is limited by specific bacterial defense strategies, such as the production of certain beta-lactamase enzymes that chemically destroy the Cefixime molecule before it can reach its target. Furthermore, the mechanism cannot operate if the bacterial target (PBP) is structurally altered by the microbe, which prevents the drug from binding effectively. The resulting destruction of the bacterial cell through osmotic pressure contributes to the reduction of the bacterial load.

Dosage and Administration Information

How to Use Ceftoral: Official Administration Guidelines

Ceftoral (Cefixime) is strictly for oral administration, utilizing approved forms such as tablets, capsules, chewable tablets, and a powder for oral suspension.


Standard Dosage and Scheduling

The standard adult dose is 400 mg daily. This quantity may be administered in one single dose or divided into two 200 mg doses taken every 12 hours. For certain specific infections, a single 400 mg dose is specified. Cefixime can be taken with or without food as the presence of a meal does not significantly alter its absorption.


Course Duration and Procedural Requirements

The total duration of use typically ranges from 7 to 14 days. However, when treating infections caused by Streptococcus pyogenes (e.g., pharyngitis or tonsillitis), the medicine must be administered for a minimum of 10 days to ensure complete eradication.

Proper administration requires attention to the form: the oral suspension must be reconstituted with water and shaken vigorously prior to use, and chewable tablets must be chewed completely before being swallowed.


Population-Specific Dosing

For pediatric patients (ages ge 6 months), the dose is calculated at 8 mg/kg of body weight per day, administered once daily or divided every 12 hours. A dose adjustment is required for patients with severe renal impairment; specifically, if the Creatinine Clearance falls below 20 mL/min, the dose should not exceed 200 mg once daily.

Recent Clinical Evidence

Recent Clinical Evidence

Maintenance Treatment in COPD

Research has evaluated the effect on clinical outcomes in adults with chronic obstructive pulmonary disease (COPD) when administered as a long-term maintenance treatment. These trials primarily focused on the treatment's role over 52 weeks in adults with moderate-to-very severe COPD.

  • The primary study findings included data on the rate of moderate-to-severe exacerbations.
  • Studies assessed the change in symptoms, such as dyspnea (difficulty breathing) and cough frequency. Research explored the assessment of reported breathing difficulty.
  • Furthermore, changes in forced expiratory volume in one second (FEV1), a measure of lung function, were examined.

Comparison to Other Treatments

The combination of two active ingredients, a long-acting muscarinic antagonist (LAMA) and a long-acting beta2-agonist (LABA), was studied in comparison to monotherapy (LAMA or LABA alone).

  • Trials examined the relationship between the combination and hospitalization rates due to COPD exacerbations.
  • Studies explored whether there was a change in quality of life, including the ability to perform daily activities.
  • The results of these comparative trials were used to evaluate potential differences in the frequency of adverse events across the treatment groups.

Study Limitations and Safety Context

Studies did not evaluate whether consistent use affects outcomes. The primary endpoints did not include measures of pain and inflammation.

The clinical trials excluded participants with certain pre-existing heart conditions.

  • Data on long-term use (beyond one year) in clinical trials remains limited at this time.

Frequently Asked Questions (FAQ)

Common questions about Ceftoral (FAQ)

Q: How quickly does Ceftoral start working after I take the first dose?

The official clinical information indicates that the active ingredient, Cefixime, reaches its highest concentration in the bloodstream (known as peak serum concentration) between 2 to 6 hours after taking an oral dose. This concentration allows the medicine to begin its bactericidal action against susceptible bacteria.

Q: Can Ceftoral cause stomach issues like diarrhea or nausea?

Regulatory documents list diarrhea and nausea among the most common adverse reactions reported by patients using this medicine. Official warnings note that severe or persistent diarrhea may rarely be a sign of a secondary infection, such as C. difficile-associated diarrhea (CDAD).

Q: Does Ceftoral interact with supplements like iron or calcium?

The official product information notes that oral products containing mineral supplements like zinc or iron may interfere with how Cefixime is absorbed into the body. To support proper absorption, some clinical protocols recommend separating the administration of these types of supplements by at least 3 hours.

Q: Does Ceftoral interact with antacids or acid-reducing medications?

While regulatory labeling specifically highlights interactions with medicines like Warfarin and Probenecid, information suggests that antacids containing aluminum or magnesium may potentially reduce the absorption of Cefixime. Patients are advised to discuss all co-administered medications with a healthcare provider to review any documented interactions.

Q: Can Ceftoral affect blood sugar levels?

Ceftoral does not typically affect actual blood sugar levels. However, official warnings state that the medicine may cause a false-positive reaction for glucose (sugar) in the urine when certain testing methods, like Benedict's or Clinitest, are used. This reported effect is specific to certain lab tests and does not generally indicate a change in the body's actual blood glucose levels.

Q: What should I do if I vomit after taking a dose of Ceftoral?

There are no standardized rules for all patients, but some clinical administration guidelines, particularly for children, suggest that a dose may need to be repeated if the patient vomits within 2 hours of taking the medicine. Specific instructions regarding a repeated dose after vomiting should be obtained directly from the prescribing healthcare professional.

Q: Do older adults need a different dosage of Ceftoral?

Regulatory guidance states that elderly patients may typically receive the same dose as recommended for younger adults. However, because kidney function often changes with age, the dosage may require adjustment if severe renal impairment (reduced kidney function) is present.

Q: What's the difference between Ceftoral and penicillin?

Ceftoral (Cefixime) is classified as a cephalosporin antibiotic, which belongs to a different drug class than the penicillin family of antibiotics. For patients with a history of a severe, immediate allergic reaction to penicillins, the medicine is contraindicated due to the potential for cross-reactivity.

Q: Can Ceftoral cause an allergic reaction, and what are the signs?

Yes, serious hypersensitivity reactions (allergic reactions) are a known, though rare, risk with Ceftoral. Signs of a severe reaction can include a severe rash, hives, swelling, dizziness, and difficulty breathing, and may necessitate immediate medical attention.

Q: Why do some people experience yeast infections after taking Ceftoral?

Official information explains that antibiotics can sometimes lead to the overgrowth of non-susceptible organisms in the body, such as yeast. This overgrowth can result in a secondary infection, which is why conditions like vaginitis (often a yeast infection in women) are listed as a possible side effect.

Q: Can Ceftoral cause changes in mood or anxiety?

Adverse reaction data lists common effects such as dizziness and headache. While less common, the regulatory documentation includes reports of Central Nervous System effects, which may potentially manifest as anxiety or nervousness.

Q: Is Ceftoral available over-the-counter in any country?

Cefixime, the active ingredient in Ceftoral, is classified as a prescription-only medication in the United States and most other countries. This means it requires authorization from a healthcare professional to be dispensed.

Q: Are there generic versions of Ceftoral available?

Yes, the active ingredient, Cefixime, is widely available as a generic drug. Generic versions are manufactured and approved to meet the same quality, strength, and stability standards as the original branded product.

Q: Is Ceftoral a common treatment for ear infections?

Official labeling and authoritative pediatric guidelines indicate that Cefixime is an established treatment for certain cases of acute otitis media (middle ear infections) when they are caused by susceptible strains of bacteria.

Q: Is Ceftoral the same as Cefaclor or Cefuroxime?

No, Ceftoral contains the active ingredient Cefixime, which is categorized as a third-generation cephalosporin. Cefaclor and Cefuroxime are different, though related, cephalosporin antibiotics.

Q: What is the recommended window for taking doses of Ceftoral?

The regulatory documents state that the total daily dose of Ceftoral can be administered in one single dose or, if preferred, divided into two doses that are taken every 12 hours. The exact scheduling should be followed as prescribed.

Q: Does Ceftoral help with urinary tract infections (UTIs)?

Yes, Cefixime is officially indicated for the treatment of uncomplicated urinary tract infections (UTIs) when the infection is confirmed to be caused by specific bacteria that are susceptible to this medicine.

How should Ceftoral be stored and disposed of?

The required storage conditions for Ceftoral (Cefixime) vary based on the medicine's form.

Storage Requirements

Formulation Required Storage Condition
Tablets, Capsules, and Dry Powder Store at Controlled Room Temperature (20°C to 25°C or 68°F to 77°F), protected from moisture, and keep in the original, tightly closed container.
Reconstituted Liquid Suspension Store under refrigeration (2°C to 8°C or 36°F to 46°F). Do not freeze.

Stability and Disposal

The reconstituted liquid suspension is stable for 14 days when refrigerated. Any unused portion must be discarded after this period. All forms of Ceftoral must be kept out of the sight and reach of children. Disposal of expired or unused medicine must be conducted in accordance with local requirements for pharmaceutical waste and must not be thrown into wastewater or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ceftoral found in:

A-Z Index: